慢性胃炎临床治疗分析

目的探讨慢性胃炎患者采用奥美拉唑联合法莫替丁治疗的临床效果。方法采用回顾性方法分析,选取该院自2013年1月—2014年1月以来收治的84例慢性胃炎患者的临床资料进行回顾性分析,按照入院顺序将其分为对照组及观察组,两组分别为42例,对照组给予奥美拉唑治疗,观察组患者在此基础上联合法莫替丁治疗,比较两组患者的临床疗效及不良反应。结果观察组患者临床总有效率90.48%（38/42）明显高于对照组患者71.43%（30/42）;且不良反应率7.14%（3/42）明显低于对照组14.29%（6/42）,差异有统计学意义（P〈0.05）。结论奥美拉唑联合法莫替丁治疗慢性胃炎患者疗效确切,且不良反应少,同时在治疗期间应减少烟酒的食用,确保生活的规律性,进而提高患者的生活质量。

Analysis of the Clinical Treatment of Chronic Gastritis

Objective To investigate the clinical effect of omeprazole combined with famotidine on patients with chronic gastritis.Methods A retrospective method was used to analyze. The clinical data of 84 cases of chronic gastritis patients admitted in our hospital from January 2013 to January 2014 were selected and retrospectively analyzed. According to the order of admission, the patients were divided into the control group and the observation group with 42 cases in each. The control group were given omeprazole treatment, the patients in the observation group were given famotidine based on the treatment of omeprazole. The clinical efficacy and adverse reactions of two groups of patients were compared. Results The clinical total effective rate of the observation group was 90.48%（38/42）, which was significantly higher than the control group＇s 71.43%（30/42）; the incidence of adverse reactions was 7.14%（3/42）, obviously lower than the control group＇s 14.29%（6/42）, the differences were statistically significant（P〈0.05）. Conclusion Omeprazole combined with famotidine in the treatment of patients with chronic gastritis has exact curative effect with less adverse reactions. And during the treatment, the consumption of alcohol and tobacco should be reduced so as to ensure the regularity of life and improve the quality of life of the patients.